Literature DB >> 32132148

Associations of Abdominal Skeletal Muscle Mass, Fat Mass, and Mortality among Men and Women with Stage I-III Colorectal Cancer.

Harm van Baar1, Renate M Winkels2, Jesca G M Brouwer1, Liesbeth Posthuma1, Martijn J L Bours3, Matty P Weijenberg3, Hendriek C Boshuizen1, Moniek van Zutphen1, Fränzel J B van Duijnhoven1, Dieuwertje E Kok1, Evertine Wesselink1, Gerrit D Slooter4, Ernst J Spillenaar Bilgen5, Birgitta M E Hansson6, Johannes H W de Wilt7, Ellen Kampman1, Sandra Beijer8.   

Abstract

BACKGROUND: The associations of abdominal skeletal muscle mass index (SMI), visceral and subcutaneous adipose tissue (VAT and SAT, respectively), and mortality among patients with stage I-III colorectal cancer may differ for men and women, but only few studies stratified their data into men and women. We investigated associations of abdominal SMI, VAT, and SAT with overall mortality among men and among women with stage I-III colorectal cancer.
METHODS: SMI, VAT, and SAT were assessed from abdominal CT images for 1,998 patients with stage I-III colorectal cancer diagnosed between 2006 and 2015. Restricted cubic splines (RCS) were used to investigate associations of SMI, VAT, and SAT with overall mortality.
RESULTS: Average age of the participants was 67.9 ± 10.6 years and 58% were men. During a median follow-up of 4.3 years, 546 (27%) patients died. Among men, the association of SMI and mortality was statistically significant in a nonlinear way in the RCS analyses, with lower SMI levels associated with higher mortality. SMI was not associated with mortality among women. SAT was associated with mortality in a nonlinear way for men and for women, with lower SAT levels being associated with higher mortality. VAT was not significantly associated with mortality in men or women.
CONCLUSION: Associations of abdominal skeletal muscle mass with mortality among patients with colorectal cancer were not the same for men and for women. IMPACT: This study stresses the importance for more attention on sex-related differences in body composition and cancer outcomes. ©2020 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2020        PMID: 32132148     DOI: 10.1158/1055-9965.EPI-19-1134

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  4 in total

1.  Effects of age and gender on body composition indices as predictors of mortality in middle-aged and old people.

Authors:  Chin-Sung Chang; I-Ting Liu; Fu-Wen Liang; Chia-Chun Li; Zih-Jie Sun; Yin-Fan Chang; Ting-Hsing Chao; Chih-Hsing Wu
Journal:  Sci Rep       Date:  2022-05-12       Impact factor: 4.996

2.  Body Composition Is a Predictor for Postoperative Complications After Gastrectomy for Gastric Cancer: a Prospective Side Study of the LOGICA Trial.

Authors:  Thaís T T Tweed; Arjen van der Veen; Stan Tummers; David P J van Dijk; Misha D P Luyer; Jelle P Ruurda; Richard van Hillegersberg; Jan H M B Stoot; Juul J W Tegels; Karel W E Hulsewe; Hylke J F Brenkman; Maarten F J Seesing; Grard A P Nieuwenhuijzen; Jeroen E H Ponten; Bas P L Wijnhoven; Sjoerd M Lagarde; Wobbe O de Steur; Henk H Hartgrink; Ewout A Kouwenhoven; Marc J van Det; Eelco B Wassenaar; Edwin S van der Zaag; Werner A Draaisma; Ivo A M J Broeders; Suzanne S Gisbertz; Mark I van Berge Henegouwen; Hanneke W M van Laarhoven
Journal:  J Gastrointest Surg       Date:  2022-04-29       Impact factor: 3.267

3.  Association of visceral and subcutaneous adiposity with tumor stage and Fuhrman grade in renal cell carcinoma.

Authors:  J S F Maurits; J P M Sedelaar; K K H Aben; L A L M Kiemeney; A Vrieling
Journal:  Sci Rep       Date:  2022-10-06       Impact factor: 4.996

4.  Identification of Lifestyle Behaviors Associated with Recurrence and Survival in Colorectal Cancer Patients Using Random Survival Forests.

Authors:  Moniek van Zutphen; Fränzel J B van Duijnhoven; Evertine Wesselink; Ruud W M Schrauwen; Ewout A Kouwenhoven; Henk K van Halteren; Johannes H W de Wilt; Renate M Winkels; Dieuwertje E Kok; Hendriek C Boshuizen
Journal:  Cancers (Basel)       Date:  2021-05-18       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.